MedPath
HSA Approval

DAPTOMYCIN/ANFARM POWDER FOR SOLUTION FOR INJECTION/INFUSION 500MG/VIAL

SIN17204P

DAPTOMYCIN/ANFARM POWDER FOR SOLUTION FOR INJECTION/INFUSION 500MG/VIAL

DAPTOMYCIN/ANFARM POWDER FOR SOLUTION FOR INJECTION/INFUSION 500MG/VIAL

March 12, 2025

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

GOLDPLUS UNIVERSAL PTE LTD

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

J01XX09

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

ANFARM HELLAS S.A

Active Ingredients

Daptomycin

500mg/vial

Daptomycin

Documents

Package Inserts

Daptomycin-Anfarm Powder for Solution for Injection or Infusion PI.pdf

Approved: March 12, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DAPTOMYCIN/ANFARM POWDER FOR SOLUTION FOR INJECTION/INFUSION 500MG/VIAL - HSA Approval | MedPath